Radiotherapy in breast-conserving treatment for ductal carcinoma in situ: First results of the EORTC randomised phase III trial 10853

Lancet

Volumn 355, Issue 9203, 2000, Pages 528-533

  Julien, Jean Pierre ^a   Bijker, Nina ^b   Fentiman, Ian S ^c   Peterse, Johannes L ^b   Delledonne, Vincenzo ^d   Rouanet, Philippe ^e   Avril, Antoine ^f   Sylvester, Richard ^g   Mignolet, Françoise ^g   Bartelink, Harry ^h   Van Dongen, Joop A ^h  

^a CENTRE HENRI BECQUEREL   (France)

^b NETHERLANDS CANCER INSTITUTE   (Netherlands)

^c GUY S HOSPITAL   (United Kingdom)

^d NATIONAL CANCER INSTITUTE   (Italy)

^e CENTRE VAL D AURELLE   (France)

^f INSTITUT BERGONIÉ   (France)

^g EORTC DATA CENTER   (Belgium)

^h 1066 CX the ^*  (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER RECURRENCE; CANCER SURVIVAL; CARCINOMA IN SITU; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INTRADUCTAL CARCINOMA; MAJOR CLINICAL STUDY; MAMMOGRAPHY; PRIORITY JOURNAL; TUMOR VOLUME;

EID: 0034639637     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(99)06341-2     Document Type: Article

References (16)

1. Veronesi U., Salvadori B., Luini A.et al. Breast conservation is a safe method in patients with small cancer of the breast: long-term results of three randomised trials on 1973 patients. Eur J Cancer. 31A:1995;1574-1579.
2. Fisher B., Redmond C., Poisson R.et al. Eight-year results of a randomised clinical trial comparing total mastectomy and lumpectomy with or without irradiation in the treatment of breast cancer. N Engl J Med. 320:1989;822-828.
3. Van Dongen J.A., Bartelink H., Fentiman I.S.et al. Factors influencing local relapse and survival and results of salvage treatment after breast-conserving therapy in operable breast cancer: EORTC Trial 10801, breast conservation compared with mastectomy in TNM stage I and II breast cancer. Eur J Cancer. 28A:1992;801-805.
4. Jacobson J.A., Danforth D.N., Cowan K.H.et al. Ten-year results of a comparison of conservation with mastectomy in the treatment of stage I and II breast cancer. N Engl J Med. 332:1995;907-911.
5. Recht A., Rutgers E.J.Th., Fentiman I.S.et al. The fourth EORTC DCIS consensus meeting: conference report. Eur J Cancer. 34:1998;1664-1669.
6. Kaplan E.L., Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 53:1958;457-481.
7. Shiragai A. A proposal concerning the absorbed dose conversion factor. Phys Med Biol. 23:1978;245-252.
8. Fisher B., Costantino J., Redmond C.et al. Lumpectomy compared with lumpectomy and radiation therapy for the treatment of intraductal breast cancer. N Engl J Med. 328:1993;1581-1586.
9. Fisher B., Dignam J., Wolmark N.et al. Lumpectomy and radiation therapy for the treatment of intraductal breast cancer: findings from national surgical adjuvant breast and bowel project B-17. J Clin Oncol. 16:1998;441-452.
10. Solin L.J., Kurtz J., Fourquet A.et al. Fifteen-year results of breast-conserving surgery and definitive breast irradiation for the treatment of ductal carcinoma in situ of the breast. J Clin Oncol. 14:1996;754-763.
11. Silverstein M.J., Barth A., Poller D.N.et al. Ten-year results comparing mastectomy to excision and radiation therapy for ductal carcinoma in situ of the breast. Eur J Cancer. 31A:1995;1425-1427.
12. Silverstein M.J., Lagios M.D., Craig P.H.et al. A prognostic index for ductal carcinoma in situ of the breast. Cancer. 77:1996;2267-2274.
13. Silverstein M.J., Lagios M.D., Groshen S.et al. The influence of margin width on local control of ductal carcinoma in situ of the breast. N Engl J Med. 340:1999;1455-1461.
14. De Jong E., Peterse J.L., Van Dongen J.A. Recurrence after breast ablation for ductal carcinoma in situ. Eur J Surg Oncol. 18:1992;64-66.
15. Schnitt S.J., Silen W., Sadowski N.L., Connolly J.L., Harris J.R. Ductal carcinoma in situ (intraductal carcinoma) of the breast. N Engl J Med. 318:1988;898-903.
16. Fisher B., Dignam J., Wolmark N.et al. Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial. Lancet. 353:1999;1993-2000.